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Short title: TRAF2 regulates skin homeostasis 27 
 28 
Abstract 29 
TRAF2 is a component of TNF superfamily signalling complexes and plays an essential role 30 
in the regulation and homeostasis of immune cells. TRAF2 deficient mice die around birth, 31 
therefore its role in adult tissues is not well-explored. Furthermore, the role of the TRAF2 32 
RING is controversial. It has been claimed that the atypical TRAF2 RING cannot function as 33 
a ubiquitin E3 ligase but counterclaimed that TRAF2 RING requires a co-factor, sphingosine-34 
1-phosphate, that is generated by the enzyme sphingosine kinase 1, to function as an E3 35 
ligase. Keratinocyte specific deletion of Traf2, but not Sphk1 deficiency, disrupted TNF 36 
mediated NF-κB and MAP kinase signalling and caused epidermal hyperplasia and psoriatic 37 
skin inflammation. This inflammation was driven by TNF, cell death, non-canonical NF-κB 38 
and the adaptive immune system and might therefore represent a clinically relevant model of 39 
psoriasis. TRAF2 therefore has essential tissue specific functions that do not overlap with 40 
those of Sphk1. 41 
 42 
Introduction 43 
TNF Receptor Associated Factor 2 (TRAF2) is an adaptor protein that transduces signals 44 
following ligation of certain cytokine receptors including those binding TNF. It was first 45 
identified together with TRAF1 as a component of TNF receptor-2 and then TNF receptor-46 
1 (TNFR1) signalling complexes (Rothe, Wong, Henzel, & Goeddel, 1994; Shu, Takeuchi, 47 
& Goeddel, 1996). TRAF2, like most other TRAFs, contains a RING domain, several zinc 48 
fingers, a TRAF-N, and a conserved TRAF-C domain which is responsible for 49 
oligomerisation and receptor binding through its MATH region (Takeuchi, Rothe, & 50 
Goeddel, 1996; Uren & Vaux, 1996). 51 
 52 
RING domains are nearly always associated with ubiquitin E3 ligase activity (Shi & Kehrl, 53 
2003) and TRAF2 can promote ubiquitylation of RIPK1 in TNFR1 signalling complexes 54 
(TNFR1-SC) (Wertz et al., 2004). However TRAF2 recruits E3 ligases such as cIAPs to 55 
TNFR1-SC and these have also been shown to be able to ubiquitylate RIPK1 and regulate 56 
TNF signalling (Dynek et al., 2010; Mahoney et al., 2008; Varfolomeev et al., 2008; Vince 57 
et al., 2009). This makes it difficult to unambiguously determine the role of the E3 ligase 58 
activity of TRAF2. 59 
 60 
Activation of JNK and NF-κB by TNF is reduced in cells from Traf2-/- mice while only 61 
JNK signalling was affected in lymphocytes from transgenic mice that express a dominant 62 
negative (DN) form of TRAF2 that lacks the RING domain (Lee et al., 1997; Yeh et al., 63 
1997). Traf2-/-Traf5-/- mouse embryonic fibroblasts (MEFs) have a pronounced defect in 64 
activation of NF-κB by TNF, suggesting that absence of TRAF2 can be compensated by 65 
TRAF5 (Tada et al., 2001). Although activation of NF-κB was restored in Traf2-/-Traf5-/- 66 
cells by re-expression of wild type TRAF2, it was not restored when the cells were 67 
reconstituted with TRAF2 point mutants that could not bind cIAPs (Vince et al., 2009; 68 
Zhang, Blackwell, Shi, & Habelhah, 2010). These data, together with a wealth of different 69 
lines of evidence showing that cIAPs are critical E3 ligases required for TNF-induced 70 
canonical NF-κB (Blackwell et al., 2013; Haas et al., 2009; Silke, 2011), support the idea 71 
that the main function of TRAF2 in TNF-induced NF-κB is to recruit cIAPs to the TNFR1-72 
SC. However, it remains possible that the RING of TRAF2 plays another function, such as 73 
in activating JNK and protecting cells from TNF-induced cell death (Vince et al., 2009; 74 
Zhang et al., 2010). Furthermore it has been shown that TRAF2 can K48-ubiquitylate 75 
caspase-8 to set the threshold for TRAIL or Fas induced cell death (Gonzalvez et al., 76 
2012). Moreover, TRAF2 inhibits non-canonical NF-κB signalling (Grech et al., 2004; 77 
Zarnegar et al., 2008) and this function requires the RING domain of TRAF2 to induce 78 
proteosomal degradation of NIK (Vince et al., 2009). However, structural and in vitro 79 
analyses indicate that, unlike TRAF6, the RING domain of TRAF2 is unable to bind E2 80 
conjugating enzymes (Q. Yin, Lamothe, Darnay, & Wu, 2009), and is therefore unlikely to 81 
have intrinsic E3 ligase activity. 82 
 83 
Sphingosine-1-phosphate (S1P) is a pleiotropic sphingolipid mediator that regulates 84 
proliferation, differentiation, cell trafficking and vascular development (Pitson, 2011). S1P 85 
is generated by sphingosine kinase 1 and 2 (SPHK1 and SPHK2) (Kohama et al., 1998; 86 
Liu et al., 2000). Extracellular S1P mainly acts by binding to its five G protein-coupled 87 
receptors S1P1-5 (Hla & Dannenberg, 2012). However, some intracellular roles have been 88 
suggested for S1P, including the blocking of the histone deacetylases, HDAC1/2 (Hait et 89 
al., 2009) and the induction of apoptosis through interaction with BAK and BAX (Chipuk 90 
et al., 2012). 91 
 92 
Recently, it was suggested that the RING domain of TRAF2 requires S1P as a co-factor for 93 
its E3 ligase activity (Alvarez et al., 2010). Alvarez and colleagues proposed that SPHK1 94 
but not SPHK2 is activated by TNF and phosphorylates sphingosine to S1P which in turn 95 
the RING domain of TRAF2 and serves as an essential co-factor that was missing in the 96 
experiments of Yin et al. Alvarez and colleagues, observed that in the absence of SPHK1, 97 
TNF-induced NF-κB activation was completely abolished. 98 
 99 
Although we know a lot about TRAF2, there are still important gaps particularly with 100 
regard to cell type specificity and in vivo function of TRAF2. Moreover, despite the claims 101 
that SPHK1 and its product, S1P, are required for TRAF2 to function as a ubiquitin ligase, 102 
the responses of Traf2-/- and Sphk1-/- cells to TNF were not compared. Therefore, we 103 
undertook an analysis of TRAF2 and SPHK1 function in TNF signalling in a number of 104 
different tissues. 105 
 106 
Surprisingly, we found that neither TRAF2 nor SPHK1 are required for TNF mediated 107 
canonical NF-κB and MAPK signalling in macrophages. However, MEFs, murine dermal 108 
fibroblasts (MDFs) and keratinocytes required TRAF2 but not SPHK1 for full strength 109 
TNF signalling. In these cell types, absence of TRAF2 caused a delay in TNF-induced 110 
activation of NF-κB and MAPK, and sensitivity to killing by TNF was increased. Absence 111 
of TRAF2 in keratinocytes in vivo resulted in psoriasis-like epidermal hyperplasia and skin 112 
inflammation. Unlike TNF-dependent genetic inflammatory skin conditions, such as IKK2 113 
epidermal knock-out (Pasparakis et al., 2002) and the cpdm mutant (Gerlach et al., 2011), 114 
the onset of inflammation was only delayed, and not prevented by deletion of TNF. This 115 
early TNF-dependent inflammation is caused by excessive apoptotic but not necroptotic 116 
cell death and could be prevented by deletion of Casp8. We observed constitutive 117 
activation of NIK and non-canonical NF-κB in Traf2-/- keratinocytes which caused 118 
production of inflammatory cytokines and chemokines. We were able to reverse this 119 
inflammatory phenotype by simultaneously deleting both Tnf and Nfkb2 genes. Our results 120 
highlight the important role TRAF2 plays to protect keratinocytes from cell death and to 121 
down-regulate inflammatory responses and support the idea that intrinsic defects in 122 
keratinocytes can initiate psoriasis-like skin inflammation.  123 
 124 
Results 125 
 126 
TRAF2 and SPHK1 are dispensable for TNF signalling in macrophages. 127 
Macrophages are a major source of TNF during inflammation and also respond to it by 128 
producing other inflammatory cytokines. To examine the role of TRAF2 in TNF signalling 129 
in macrophages we generated bone marrow-derived macrophages (BMDMs), from wild 130 
type and Traf2lox/loxLyz2-Cre (Traf2LC) mice. The Lyz2-Cre recombinase transgene is 131 
expressed in all cells of the myeloid lineage including macrophages (Wong et al., 2014). 132 
TNF stimulation of wild type BMDMs caused degradation of IκBα and phosphorylation of 133 
JNK and ERK within 15 minutes (Figure 1A). In Traf2LC and Sphk1 deficient BMDMs, the 134 
kinetics of IκBα degradation and phosphorylation of JNK and ERK induced by TNF were 135 
the same as in wild type BMDMs (Figure 1A and 1B). 136 
 137 
Because activation of canonical NF-κB protects cells from TNF-induced death, we treated 138 
Traf2 deficient and wild type BMDMs with TNF for 24 hours and assayed their viability 139 
using Propidium Iodide (PI) staining and flow cytometry. Taking into account the slightly 140 
higher background death of Traf2-/- BMDMs compared with wild type BMDMs, TNF was 141 
not cytotoxic to either wild type or Traf2-/- macrophages (Figure 1C). High dose (500 nM) 142 
Smac-mimetic (SM) but not a low dose (100 nM) can induce the death of macrophages via 143 
production of autocrine TNF (Wong et al., 2014). We tested whether loss of TRAF2, could 144 
sensitise macrophages to low dose SM. As previously reported, wild type macrophages 145 
were resistant to killing by low dose SM, but Traf2LC BMDMs were very sensitive (Figure 146 
1C). To find out why, we measured the concentration of TNF secreted by BMDMs into the 147 
culture media following stimulation with TNF or SM. TNF secretion was undetectable 148 
earlier than 20 hours TNF stimulation and there was no significant difference in the 149 
amount of TNF secreted by wild type or TRAF2LC macrophages at this time point (Figure 150 
1D; upper panel). In contrast, after four hours of treatment with SM, very large amounts of 151 
TNF could be detected in both the wild type and Traf2LC macrophages (Figure 1D; lower 152 
panel). Although initially similar amounts of TNF were produced, after 8 hours the amount 153 
of TNF secreted by the Traf2LC macrophages was less than that made by the wild type 154 
macrophages (Figure 1D; lower panel). This is likely due to SM induced death of 155 
TRAF2LC but not wild type BMDMs (Figure 1C). 156 
 157 
TRAF2 but not SPHK1 is needed for normal TNF signalling in fibroblasts and 158 
keratinocytes. 159 
Since TRAF2 was not required for TNF signalling in BMDMs, we could not use this cell 160 
type to determine whether SPHK1-derived S1P was required as an essential co-factor for 161 
TRAF2s E3 ligase activity. Therefore we extended our analysis to other cell types and 162 
generated MEFs and MDFs lacking TRAF2 or SPHK1 and compared their response to 163 
TNF with wild type cells. Consistent with earlier reports (Tada et al., 2001; Vince et al., 164 
2009; Zhang et al., 2010), loss of TRAF2 in MEFs caused a delay in, but did not abolish, 165 
TNF-induced NF-κB activation and JNK phosphorylation (Figure 2A). Similarly, loss of 166 
TRAF2 in MDFs caused a delay in both NF-κB and MAPK signalling activation (Figure 167 
2B). However no such delay was observed in Sphk1 knock-out cells (Figure 2A and 2B). 168 
Consistent with earlier findings (Vince et al 2009; Zhang et al 2010), Traf2 knock-out 169 
MEFs and MDFs were sensitive to TNF-induced cell death, however wild type and Sphk1-/- 170 
cells remained resistant (Figure 2C). The sensitivity to TNF-induced cell death correlated 171 
with caspase-8 and -3 cleavage in Traf2-/- fibroblasts (Figure 2B). 172 
 173 
To test the function of TRAF2 in primary keratinocytes and compare its role to that of 174 
SPHK1 in TNF signalling, we generated epidermal specific Traf2 deficient mice 175 
(Traf2EKO) by crossing Traf2lox/lox mice with transgenic mice constitutively expressing Cre 176 
recombinase under the control of the keratin-14 promoter (K14-Cre). Primary 177 
keratinocytes isolated from wild type, Traf2EKO and Sphk1-/- mice were tested and, 178 
similarly to MEFs and MDFs, TNF signalling was delayed and weakened in Traf2 179 
deficient (Figure 2D), but not Sphk1 deficient keratinocytes (Figure 2E). Traf2-/-, but not 180 
Sphk1-/-, keratinocytes were also sensitive to TNF-induced death (Figure 2F), and this was 181 
associated with a rapid reduction in cFLIPL levels and caspase-8 cleavage (Figure 2D). 182 
Treatment with the pan-caspase inhibitor Q-VD-OPh (QVD) reduced TNF-induced death 183 
of Traf2-/- cells by about half (Figure 2F). On its own, the RIPK1 kinase inhibitor, 184 
Necrostatin (Nec), reduced TNF-induced cell death, but this reduction is not statistically 185 
significant. However, the combination of QVD and Nec completely blocked TNF-induced 186 
cell death in Traf2-/- keratinocytes (Figure 2F). 187 
 188 
RIPK1 ubiquitylation is delayed in Traf2-/- MDFs, but normal in Sphk1-/- cells. 189 
Alvarez et al. proposed that SPHK1 and its product S1P are required for ubiquitylation of 190 
RIPK1 by TRAF2 (Alvarez et al., 2010). However, the preponderance of evidence, both 191 
genetic and biochemical, suggests that TRAF2 serves to recruit cIAPs and that these are 192 
the main E3 ligases for RIPK1 (Mahoney et al., 2008; Silke, 2011; Varfolomeev et al., 193 
2008; Vince et al., 2009). To explore this issue further, we examined RIPK1 ubiquitylation 194 
upon TNF stimulation in wild type, Traf2-/- and Sphk1-/- MDFs using the tandem ubiquitin 195 
binding entities (TUBE) beads to immuno-precipitate ubiquitylated proteins. Within 5 to 196 
15 minutes of TNF stimulation RIPK1 became strongly ubiquitylated in both wild type and 197 
Sphk1-/- MDFs and this decreased over 60 minutes (Figure 3A and 3B). In Traf2-/- cells, 198 
this ubiquitylation was not observed at early time points (5 or 15 minutes), but occurred 199 
after 60 minutes with a different pattern (Figure 3A and 3B). This delayed ubiquitylation 200 
correlated with the delayed NF-κB activation observed in Traf2-/- cells (Figure 2A, 2B & 201 
2D). cIAP1 and phospho-ERK migrated as high molecular weight species, suggestive of 202 
ubiquitylation, within 15 minutes of TNF stimulation in wild type and Sphk1-/-, but this 203 
ubiquitylation was delayed in Traf2-/- MDFs (Figure 3A & 3B). Consistent with the 204 
previous results, cleaved caspase-8 appeared in Traf2-/- MDFs after one hour TNF 205 
stimulation (Figure 3B). 206 
 207 
Loss of TRAF2 in keratinocytes causes epidermal hyperplasia and psoriasis-like 208 
inflammation. 209 
The role of TRAF2 in homeostasis of lymphocytes has been well-studied (Silke & Brink, 210 
2010). However, the role of TRAF2 in adult epithelial cells has not yet been reported. 211 
TRAF2 was detected at high or medium levels in 36 out of 81 normal human tissue cell 212 
types, and in the skin, dermal fibroblasts and keratinocytes (Uhlen et al., 2015). To 213 
discover the role of TRAF2 in keratinocytes we aged and monitored Traf2lox/lox-K14-Cre 214 
(Traf2EKO) mice. Traf2EKO mice were born at the expected Mendelian ratios but developed 215 
an inflamed skin phenotype from 6 weeks of age. This phenotype became worse over time 216 
and the mice were sacrificed usually before 15 weeks of age (Figure 4A & 4F). The 217 
epidermal layer in a normal mouse is usually comprised of 2-3 layers of keratinocytes 218 
(Gudjonsson, Johnston, Dyson, Valdimarsson, & Elder, 2007), however histological skin 219 
sections from Traf2EKO mice revealed a grossly thickened epidermis (Figure 4B). 220 
Normally, the epidermis expresses keratin-14, but keratin-6 expression is confined to hair 221 
follicles or hyper-proliferative keratinocytes. The Traf2EKO epidermis was highlighted by 222 
widespread expression of both of these markers (Figure 4B). Excessive leukocyte 223 
infiltration and apoptotic death were also detected in the inflamed area of Traf2EKO by 224 
immuno-staining of CD45 (leukocyte common antigen) and cleaved caspase-3 (CC3) 225 
respectively (Figure 4B). We did not detect any significant infiltration of mast cells into 226 
the inflamed area of Traf2EKO mice by toluidine blue staining (Figure 4B). 227 
 228 
Skin inflammation induced by loss of TRAF2 partially depends on TNF. 229 
Previous studies have shown that defective TNF signalling leads to inflammation in the 230 
skin and deletion of TNF or TNFR1 prevents this phenotype. In the cpdm (SHARPIN 231 
mutant) mouse, loss of one allele of Tnf significantly reduced the systemic inflammatory 232 
disorder (Gerlach et al., 2011). Based on the presence of apoptotic cells in the epidermal 233 
layer of Traf2EKO mice (Figure 4B), spontaneous secretion of TNF by Traf2-/- keratinocytes 234 
in culture (Figure 4C) and the disrupted TNF signalling in Traf2-/- keratinocytes (Figure 235 
2D), we hypothesised that depletion of TNF would also prevent the inflammation in skin 236 
of Traf2EKO mice. Therefore, Traf2EKO mice were crossed to Tnf-/- mice. Consistent with 237 
our hypothesis, Traf2EKOTnf-/- mice did not develop epidermal hyperplasia and skin 238 
inflammation at the same time as Traf2EKO mice (Figure 4D). However, at around 20 239 
weeks after birth (10 weeks later than Traf2EKO), the skin of most of the Traf2EKOTnf-/- mice 240 
started to become inflamed. Lesions became severe enough by 30 weeks, which 241 
necessitated sacrifice of the affected animals (Figure 4D & 4F). 242 
 243 
Histological analysis revealed leukocyte infiltration into the dermis of 10 week-old 244 
Traf2EKOTnf-/- mice was also reduced when compared to age-matched Traf2EKO mice, but 245 
increased by 23 weeks (Figure 4E). There was no evidence for apoptotic, cleaved caspase 3 246 
(CC3) positive cells in the skin of Traf2EKOTnf-/- mice at any age, suggesting that cell death 247 
is induced by TNF in the Traf2-/- mice (Figure 4B) and that increased proliferation can be 248 
genetically separated from apoptotic cell death. 249 
 250 
Apoptotic cell death is the inducer of the early skin inflammation in Traf2EKO mice. 251 
Because TNF-induced death in Traf2-/- keratinocytes was only partially attenuated by Q-252 
VD-OPh but was completely blocked by the combination of Q-VD-OPh and Necrostatin 253 
(Figure 2F), we hypothesised that keratinocytes might be undergoing a necroptotic cell 254 
death that could contribute to skin inflammation (Pasparakis & Vandenabeele, 2015). 255 
However, depletion of MLKL, an essential necroptosis effector (Murphy et al., 2013; Sun 256 
et al., 2012) did not prevent or alter the onset of the skin inflammation in Traf2EKO mice 257 
(Figure 5A and 5B). Deficiency of both MLKL and caspase-8 did however rescue the early 258 
skin inflammation in Traf2EKO (Figure 5A and 5B) but the mice could not be aged further 259 
because Mlkl-/-Casp8-/- mice develop lymphadenopathy before 15 weeks of age (S. 260 
Alvarez-Diaz et al., personal communication, October 2015). To molecularly define the 261 
type of TNF-induced cell death in Traf2-/- keratinocytes, we looked at the necroptotic and 262 
apoptotic markers upon TNF stimulation in detail (Figure 5C & 5D). Oligomerisation of 263 
MLKL in the membrane fraction is a marker for execution of necroptosis (Hildebrand et 264 
al., 2014) and did not occur following 5 hours of TNF stimulation, but was only seen when 265 
caspases were inhibited by Q-VD-OPh (Figure 5C). As expected, however, 266 
oligomerisation of MLKL induced by TNF and Q-VD-OPh treatment, was blocked by 267 
Necrostatin (Figure 5C). 268 
 269 
Psoriasis-like inflammation in Traf2EKO mice is characterised by skin infiltration of 270 
neutrophils and IFNγ producing CD4+ T cells in. 271 
To characterise the type of inflammation in Traf2EKO and Traf2EKOTnf-/- mice, we analysed 272 
skin sections of 10 week-old Traf2EKO and 20 week-old Traf2EKOTnf-/- for infiltrating 273 
inflammatory leukocytes using flow cytometry. The skin from Traf2EKO and Traf2EKOTnf-/- 274 
mice had higher numbers of CD11b+Ly6G+ neutrophils in the epidermal and dermal layers 275 
compared to wild type skin (Figure 6A, 6B, 6C and 6D). CD4+ T cells were also abundant 276 
in the inflamed skin of Traf2EKO and Traf2EKOTnf-/- (Figure 6E & 6F). Surprisingly, IFNγ 277 
producing CD4+ T cells were significantly more abundant in the skin of Traf2EKOTnf-/- than 278 
Traf2EKO (Figure 6G). To investigate whether IFNγ production by these T cells contributed 279 
to the inflammatory phenotype, we lethally irradiated Traf2EKO mice and reconstituted 280 
them with bone marrow cells from Traf2EKO (which harbour wild type bone marrow cells) 281 
or Ifng-/- mice. However, both wild type and Ifng-/- chimeras developed skin inflammation 282 
to the same extent indicating that IFNγ is not a major contributor to the psoriasis-like skin 283 
inflammation (Figure 7). 284 
 285 
Loss of TRAF2 causes constitutive non-canonical NF-κB activation and expression of 286 
inflammatory cytokine in keratinocytes. 287 
As TNF depletion only delayed and did not prevent the inflammatory skin phenotype and 288 
there were infiltrating leukocytes in the skin of Traf2EKOTnf-/- mice, this implied that there 289 
were factor(s) expressed by keratinocytes that attracted these inflammatory cells 290 
independently of TNF. TRAF2 suppresses non-canonical NF-κB activation in many 291 
different cell types and loss of TRAF2 induces constitutive activation of non-canonical 292 
NF-κB (Grech et al., 2004; Lin et al., 2011; Vallabhapurapu et al., 2008; Vince et al., 293 
2007; Zarnegar et al., 2008). We therefore hypothesised that loss of Traf2 in keratinocytes 294 
might induce activation of non-canonical NF-κB and thereby drive expression of 295 
inflammatory genes. To test this hypothesis we analysed the status of NIK and 296 
NFκB2/p100 processing in Traf2-/- keratinocytes. Consistent with non-canonical NF-κB 297 
activation, NIK was readily detectable in Traf2-/- but not wild type keratinocytes and there 298 
were higher levels of p52 in these cells. This activation of non-canonical NF-κB was likely 299 
independent of TNF because stimulation of these cells for 2 hours with TNF did not 300 
change the level of NIK or p52 (Figure 8A). To investigate whether increased non-301 
canonical NF-κB caused an increase in keratinocyte proliferation, which might account for 302 
the thickened epidermis, we measured the numbers of metabolically active cells every day 303 
over 5 days using an MTS-PMS assay in wild type and Traf2-/- keratinocytes on a Tnf-/- 304 
background (as a surrogate marker for proliferation). However, no difference was observed 305 
in the proliferation of Traf2-/- versus wild type keratinocytes (Figure 8B). To 306 
simultaneously control for the genotypes of the keratinocytes and the accuracy of the MTS 307 
assay, keratinocytes were treated with TNF for 24 hours after 5 days in culture. As 308 
expected Traf2-/- keratinocytes were sensitive to TNF and gave a very low MTS value, 309 
while Traf2+/- keratinocytes, generated from littermate controls, were resistant to TNF-310 
induced death (Figure 8B). 311 
 312 
IL-17 plays a major role in psoriasis and has been shown to induce proliferation of 313 
keratinocytes (Ha et al., 2014). On the other hand TRAF3 can inhibit IL-17 signalling (Zhu 314 
et al., 2010). Considering that TRAF2 and 3 usually act together (Gardam, Sierro, Basten, 315 
Mackay, & Brink, 2008; Jabara et al., 2002; Vallabhapurapu et al., 2008; Zarnegar et al., 316 
2008), we investigated whether loss of TRAF2 affected IL-17 signalling. However, loss of 317 
TRAF2 did not affect IL-17 signalling in Traf2-/- keratinocytes as assessed by IκBα 318 
degradation and phosphorylation of p65 and p38 (Figure 8C). Moreover, stimulation of 319 
keratinocytes by IL-17 did not induce proliferation of keratinocytes either in wild type or 320 
Traf2-/- keratinocytes in vitro (Figure 8D). 321 
 322 
To examine the impact of constitutive activation of non-canonical NF-κB transcription 323 
factor on the expression of inflammatory genes in keratinocytes, we used a qPCR 324 
"inflammation array" to measure more than 600 inflammatory genes. We isolated and 325 
cultured keratinocytes from Traf2EKO/+ and Traf2EKO mice both on a Tnf-/- background to 326 
avoid the effect of autocrine TNF. After 48 hrs starvation (to exclude any extrinsic signal 327 
by the serum) and without any stimulation (to look at the intrinsic effect of non-canonical 328 
NF-κB transcription factor), cells were lysed and their RNA were extracted and analysed 329 
by the qPCR array. Out of more than 600 inflammatory genes analysed, about 300 genes 330 
were constitutively expressed in the keratinocytes under these conditions (Figure 8E). The 331 
signature of inflammatory genes expression was changed in Traf2-/-Tnf-/- compared to 332 
Traf2+/-Tnf-/- keratinocytes (Figure 8E). Many inflammatory genes, such as Csf1 (M-CSF), 333 
IL-23, TNFSF9 (4-1BBL), Cr1l and Cxcl16, were highly elevated in Traf2-/-Tnf-/- 334 
keratinocytes (an excel list and zoom-able heat map of 338 expressed genes are available 335 
as Figure 8- source data 1 and 2). 336 
 337 
Blocking non-canonical NF-κB signalling and depletion of TNF together prevent 338 
inflammation caused by TRAF2 deficiency in keratinocytes. 339 
Deletion of one allele of NIK prevents lethality of Traf2 knock-out (Lin et al., 2011; 340 
Vallabhapurapu et al., 2008). Together with the observation that TRAF2 knock-out 341 
keratinocytes also have high levels of NIK and the active form of NFκB2 (p52), we 342 
hypothesised that inhibiting non-canonical NF-κB signalling, might prevent the 343 
inflammation in Traf2EKO mice. To test this, we crossed Traf2EKO with either Map3k14 344 
(Nik)aly/aly mice, that bear an inactive point mutant of NIK, or Nfkb2 (p100)-/- mice. 345 
Contrary to our hypothesis, deficiency in Map3k14 or Nfkb2 did not prevent the psoriasis-346 
like skin disease in Traf2EKO mice (Figure 9 and 10). Not only did Traf2EKOMap3k14aly/+ 347 
and Traf2EKOMap3k14aly/aly mice develop skin inflammation, the onset of disease in 348 
Traf2EKOMap3k14aly/aly mice was earlier than in Traf2EKO or Traf2EKOMap3k14aly/+ mice 349 
(Figure 9). Traf2EKONfkb2-/- mice developed epidermal hyperplasia and skin inflammation 350 
in the same time frame as Traf2EKO animals (Figure 10). Furthermore, the location of skin 351 
disease in both Traf2EKOMap3k14aly/aly and Traf2EKONfkb2-/- was different to that in 352 
Traf2EKO animals (Figure 9A and 10C). Loss of Traf2 usually caused lesions in the 353 
submental and forehead area, while lesions in Traf2EKOMap3k14aly/aly and Traf2EKONfkb2-/- 354 
mice appeared around the legs and sometimes spread over the whole ventral area (Figure 355 
9A, 10A & 10C). We were unable to examine Traf2EKOTnf-/-Map3k14aly/aly mice because 356 
Tnf-/-Map3k14aly/aly mice were highly susceptible to infections and difficult to breed (Data 357 
not shown). However, depletion of both TNF and NF-κB2 completely prevent the 358 
psoriasis-like inflammation in the Traf2EKO mice (Figure 10). Three out of thirteen of the 359 
Traf2EKOTnf-/-Nfkb2-/- mice developed skin lesions at an early age around the mouth and 360 
anus (Figure 10C & 10D). This is likely to be due to the susceptibility of NFκB2 deficient 361 
mice to opportunistic infections because both Tnf-/-Nfkb2-/- and Traf2EKO/EKONfkb2-/- mice 362 
also succumbed to such infections (Figure 10C and (Shinkura et al., 1996; L. Yin et al., 363 
2001). However, most of the Traf2EKOTnf-/-Nfkb2-/- mice were healthy up to 36 weeks of 364 
age without showing any sign of inflammation (Figure 10).  365 
Discussion 366 
TRAF2 is believed to play a key role in TNF signalling, but this hypothesis has not been 367 
tested in all tissues, and there is conflicting data on its role. Some of the strongest evidence 368 
from knock-out and dominant negative TRAF2 transgenic mice, suggests that loss of 369 
TRAF2 delays or reduces TNF-induced NF-κB and JNK and is required to protect cells 370 
from TNF-induced death (Lee et al., 1997; Yeh et al., 1997). How TRAF2 might perform 371 
these functions is not clear. On the one hand a ∆RING TRAF2 is unable to protect Traf2-/-372 
Traf5-/- cells from TNF-induced death even though it is sufficient to reconstitute TNF-373 
induced NF-κB (Vince et al., 2009; Zhang et al., 2010). This suggests that the E3 ligase 374 
activity of TRAF2 is not required for TNF-induced NF-κB but is required to protect cells 375 
from TNF-induced death. On the other hand it has been demonstrated that the RING 376 
domain of TRAF2 is atypical and seemingly unable to recruit E2 ubiquitin conjugating 377 
enzymes (Q. Yin et al., 2009). A potential resolution for this conundrum was proposed by 378 
Alvarez et al. who suggested that the RING of TRAF2 required a lipid co-factor, S1P, to 379 
function as an E3 ligase (Alvarez et al., 2010). However this solution is problematic 380 
because these authors showed that loss of SPHK1, and therefore S1P, prevented TNF-381 
induced ubiquitylation of RIPK1 and TNF-induced activation of NF-κB; yet neither of 382 
these two events depends upon the RING finger of TRAF2 (Vince et al., 2009; Zhang et 383 
al., 2010). Another difficulty with the Alvarez interpretation of their data is that Sphk1-/- 384 
mice are viable and relatively normal (Allende et al., 2004), while Traf2 knock-outs on 385 
C57BL/6 background die before or shortly after birth (Yeh et al., 1997) and on BALB/c 386 
background develop a severe colitis and die within three weeks after birth (Piao et al., 387 
2011). However, if their hypothesis is correct then the phenotype of the Sphk1 deficient 388 
mice should be equal to, if not more severe than, that of Traf2-/- mice. Two groups have 389 
explored the implications of the Alvarez finding further: Adada et al. showed that SPHK1 390 
is required for activation of MAPK p38 but not NF-κB after TNF stimulation (Adada et 391 
al., 2013), while Xiong et al. showed that neither SPHK1 nor SPHK2 are required for TNF 392 
mediated activation of NF-κB and MAP kinases in macrophages (Xiong et al., 2013). 393 
 394 
To explore this problem we performed a detailed analysis of TRAF2 function using cells 395 
from a number of different Traf2-/- tissues and compared their responses to TNF with 396 
Sphk1-/- cells. Surprisingly, Traf2 or Sphk1 deficient BMDMs activated NF-κB, JNK and 397 
ERK like wild type cells in response to TNF, and were insensitive to TNF-induced cell 398 
death. However, Traf2-/- cells were more sensitive than wild type cells to Smac-mimetic 399 
induced killing, showing that loss of TRAF2 increases the sensitivity of BMDMs to TNF if 400 
cIAPs are absent. There might be two reasons for this extra sensitivity: TRAF2 might 401 
recruit other E3 ligases that provide some protection in the absence of cIAPs from TNF-402 
induced killing, alternatively, it has been reported that TRAF2 can K48-ubiquitylate 403 
caspase-8 and promote its proteosomal degradation thereby inhibiting TRAIL induced 404 
apoptosis (Gonzalvez et al., 2012). TRAF2 might therefore play a similar role downstream 405 
of TNFR1 in macrophages leading to more TNF-induced death in the absence of cIAPs. 406 
 407 
Because loss of TRAF2 had no noticeable effect on TNF signalling in macrophages, we 408 
were unable to compare the role of TRAF2 and SPHK1 in TNF signalling. Therefore we 409 
extended our investigation into the role of TRAF2 and SPHK1 in MEFs, MDFs and 410 
keratinocytes. These cells required TRAF2 for full strength TNF signalling and TRAF2 411 
deficiency made them sensitive to TNF-induced death. However, SPHK1 deficiency did 412 
not affect either NF-κB or MAPK activation in these cells and they were resistant to TNF-413 
induced death. Consistent with these data we found that ubiquitylation of RIPK1 upon 414 
TNF stimulation was normal in Sphk1 knock-out MDFs but delayed and weakened in 415 
Traf2-/- MDFs. TRAF2 has been shown to ubiquitylate the large subunit of caspase-8 and 416 
inhibit FasL or TRAIL-induced apoptotic cell death in human cell lines (Gonzalvez et al., 417 
2012). However, we did not detect any caspase-8 ubiquitylation upon TNF stimulation in 418 
MDFs. These data indicate that role of TRAF2 in TNF signalling is cell type specific. In 419 
cell types where TRAF2 is required for TNF signalling our data is in line with earlier 420 
studies on Traf2-/- or dominant negative transgenic mice because we see defects in JNK 421 
activation and delayed NF-κB activation (Lee et al., 1997; Yeh et al., 1997). However in 422 
cell types where loss of TRAF2 results in defective TNF signalling we were unable to 423 
detect any equivalent defect in Sphk1 deficient cells arguing against the idea that S1P is an 424 
essential cofactor required for TNF-induced, TRAF2 dependent, NF-κB. 425 
 426 
Studies on TRAF2 deficient B cells revealed a crucial role for TRAF2 in B cell 427 
development and examined the consequences of Traf2 deficiency on CD40 and BAFF 428 
signalling (Gardam et al., 2008; Hostager, Haxhinasto, Rowland, & Bishop, 2003). Aside 429 
from lymphocytes however, a physiological role for TRAF2 in cells or tissues has not been 430 
well defined. Recent studies suggest that TRAF2 could have a crucial role in adult tissue 431 
homeostasis; three weeks old Traf2-/- mice on the BALB/c background developed 432 
spontaneous colitis and this phenotype was due to the death of the colonic epithelium (Piao 433 
et al., 2011). In another study, intraperitoneal injection of Tamoxifen to Traf2loxp/loxpRosa-434 
Cre-ERT2 mice induced inflammation in the intestine and mortality after one week 435 
(Petersen et al., 2015). However, it is not entirely clear that whether these defects are due 436 
to the loss of TRAF2 in epithelial cells or hematopoietic cells. Therefore we specifically 437 
targeted Traf2 in keratinocytes and investigated the role of TRAF2 in the epidermis. 438 
Keratinocyte specific Traf2 knock-out mice developed epidermal hyperplasia and severe 439 
skin inflammation leading to noticeable lesions around head and submental area by 6 440 
weeks of age. However, consistent with previous reports (Allende et al., 2004; Xiong et 441 
al., 2013), no sign of inflammation was detected in the skin of Sphk1f/fSphk2-/-Rosa-Cre-442 
ERT2 mice following activation of Cre-mediated gene deletion with Tamoxifen (Data not 443 
shown). Thus, total lack of SPHK isoenzymes did not phenocopy the skin defects seen in 444 
the absence of TRAF2 again arguing against an essential role for S1P in TRAF2's function. 445 
 446 
Several mouse models of skin inflammation have been rescued by depletion of TNF 447 
(Gerlach et al., 2011; Nenci et al., 2006; Pasparakis et al., 2002). While TNF is a major 448 
inflammatory mediator and directly driving production of a host of inflammatory cytokines 449 
through TNFR1 signalling, it has been proposed that TNF-induced cell death, specifically 450 
necroptosis, might also generate Damage Associated Molecular Patterns (DAMPs), that 451 
could activate Toll Like Receptors, or other analogous receptors to indirectly promote 452 
inflammatory cytokine production (Gerlach et al., 2011; Pasparakis & Vandenabeele, 453 
2015). The relative contribution of these two pathways to inflammation in vivo, and 454 
particularly human pathology, is still unclear. Keratinocyte hyperplasia in Sharpincpdm/cpdm 455 
mice can be driven by TNF-induced apoptotic death, because deletion of just one allele of 456 
Casp8 or epidermal Fadd deletion markedly ameliorated or prevented the TNFR1 457 
dependent inflammatory phenotype (Kumari et al., 2014; Rickard, Anderton, et al., 2014). 458 
Furthermore, epidermal cFlip (cflar) knock-out causes excessive apoptotic death and an 459 
initial wave of very rapid hyperplasia in the epidermis that is rescued by TNF inhibition 460 
(Panayotova-Dimitrova et al., 2013). Complicating this picture, caspase-8 deficiency in 461 
keratinocytes also causes inflammation in the skin and this is rescued partially by Tnf or 462 
Tnfr1 deletion (Kovalenko et al., 2009). However in this case the inflammation was 463 
attributed to constitutive activation of Interferon Regulatory Factor-3 (IRF3), which 464 
induces the expression of cytokines and chemokines in the epidermis of casp8 epidermal 465 
knock-out independently of TNF (Kovalenko et al., 2009). The skin inflammation of 466 
epidermal caspase-8 deficient mice (Weinlich et al., 2013), but not of epidermal cFlip 467 
deficient mice (Panayotova-Dimitrova et al., 2013), is completely rescued by loss of 468 
RIPK3. Therefore, Weinlich et al. suggested that necroptosis is the cause of inflammation 469 
in the epidermal casp8 knock-out. Similarly, FaddEKO, Ripk1EKO and Ripk1-/- mice develop 470 
skin inflammation that has been attributed to RIPK3/ dependent necroptosis, highlighting 471 
the importance of this pathway in the skin (Bonnet et al., 2011; Dannappel et al., 2014; 472 
Dillon et al., 2014; Rickard, O'Donnell, et al., 2014). In our model, TNF deficiency only 473 
delayed the Traf2EKO skin phenotype and did not rescue it completely and inflammation 474 
induced by loss of TRAF2 was not prevented by loss of the necroptotic effector MLKL. 475 
This was consistent with our analyses on the type of TNF-induced cell death in Traf2-/- 476 
keratinocytes, which was predominantly apoptotic. Therefore, we have crossed Traf2EKO to 477 
Mlkl-/-Casp8-/- mice and rescued the early TNF-dependent skin inflammation. 478 
Unfortunately, we were unable to age these mice more than 15 weeks as they developed 479 
lymphadenopathy and could therefore not examine the effect of Mlkl-/-Casp8-/- on the late 480 
onset inflammation in the skin. Recently it has been shown that apoptotic cells could also 481 
release DAMPs such as ATP (Poon et al., 2014) and our results support the idea that 482 
excessive apoptosis can be inflammatory. 483 
 484 
Although the microscopic phenotypes of Traf2EKO or Traf2EKOTnf-/- were similar to human 485 
psoriatic lesions, we are not sure if the infiltration of the immune cells entirely resembles 486 
the human psoriasis. In our models we observed infiltration of neutrophils and IFNγ 487 
producing CD4+ T cells to the skin which is similar to human psoriasis. However, dermal 488 
dendritic cells, macrophages, other subtypes of T helper cells (Th2 and Th17) and 489 
cytotoxic T cells have also been reported to have essential roles in initiation and 490 
development of psoriasis (Nestle, Di Meglio, Qin, & Nickoloff, 2009). More investigation 491 
about the involvement of different immune cells in different stages of the disease is clearly 492 
warranted. 493 
 494 
While Tnf deficiency delayed the appearance of the inflammatory skin phenotype in 495 
Traf2EKO mice, at later time points the epidermis thickened and there was a leukocyte 496 
infiltration. Because Traf2 deficiency is specific to keratinocytes this implies that there are 497 
one or more keratinocyte intrinsic factors that either promote proliferation and attract 498 
inflammatory cells to the skin or attract inflammatory cells, which promote keratinocyte 499 
proliferation. One possibility is that the constitutive non-canonical NF-κB signalling 500 
observed in Traf2EKOTnf-/- keratinocytes promotes their proliferation. However, in contrast 501 
to Traf2-/- lymphocytes (Gardam et al., 2008), proliferation of Traf2EKOTnf-/- keratinocytes 502 
in culture was not altered compared to controls. This suggests that epidermal hyperplasia in 503 
the Traf2EKOTnf-/- mice is not the result of an intrinsic growth advantage of Traf2-/- 504 
keratinocytes. IL-17 plays an important role in inflammatory diseases and monoclonal 505 
antibodies targeting IL-17 such as secukinumab and ixekizumab are performing well in 506 
psoriasis patients (Tse, 2013). These successes indicate that IL-17 plays an important role 507 
in human psoriasis and it has been shown that IL-17 can induce proliferation of 508 
keratinocytes in vivo (Ha et al., 2014). TRAF3 interacting protein 2 and TRAF3 have been 509 
linked to IL-17 signalling (Qian et al., 2007; Zhu et al., 2010) where TRAF3 negatively 510 
regulates IL-17 receptor signalling. We therefore considered that loss of TRAF2 might 511 
have a similar effect to loss of TRAF3 and that IL-17 might promote keratinocyte 512 
proliferation in TRAF2 deficient keratinocytes. However, in our experiments IL-17 did not 513 
increase Traf2EKO/EKOTnf-/- keratinocyte proliferation compared to Traf2EKO/+Tnf-/- cells in 514 
vitro and loss of TRAF2 had no impact on IL-17 mediated activation of NF-κB and p38 in 515 
keratinocytes. While this does not exclude a role for IL-17 in the psoriasis-like skin 516 
phenotype observed in Traf2EKO or Traf2EKOTnf-/- mice we hypothesized that Traf2EKOTnf-/- 517 
keratinocytes produced other factors to recruit inflammatory cells to the skin. 518 
 519 
We therefore analysed and compared supernatants from Traf2EKO/EKOTnf-/- and 520 
Traf2EKO/+Tnf-/- keratinocytes using Mass Spectrometry, Western blot and ELISA. 521 
However we were unable to detect cytokines such as IL-6, IL-23, IL-24, IL-33, TSLP, IL-522 
18, MCP-1 and GM-CSF using these methods (Data not shown). This failure might be due 523 
to low levels of secretion of these factors by keratinocytes maintained in serum free media 524 
so we investigated the transcription of inflammatory genes. At the mRNA level, several 525 
inflammatory genes were highly elevated in Traf2EKO/EKOTnf-/- compared to Traf2EKO/+Tnf-/- 526 
keratinocytes and many of these such as M-CSF and IL-23, have been implicated in the 527 
development of inflammatory diseases (Nair et al., 2009; van Nieuwenhuijze et al., 2013; 528 
Yoshiki et al., 2014). 529 
 530 
Depletion of non-canonical NF-κB signalling prevents early lethality in Traf2-/- mice (Lin 531 
et al., 2011; Vallabhapurapu et al., 2008) but did not rescue the Traf2EKO skin phenotype in 532 
our model. Surprisingly, the inflammatory lesions appeared with a different pattern in 533 
Traf2EKONikaly/aly and the onset of inflammation was even earlier than in Traf2EKO mice. 534 
This could be either due to the susceptibility of Nikaly/aly to autoimmunity that is 535 
exacerbated by the loss of TRAF2 or there could be another unknown pathway inhibited by 536 
TRAF2 that is worsened by NIK mutation. In Traf2EKONfkb2-/- animals, the onset of 537 
inflammation was similar to Traf2EKO mice, but the development of disease was slightly 538 
slower and mice survived marginally longer. 539 
 540 
These data show that TNF-dependent cell death, but not non-canonical NF-κB, is a driver 541 
of the early inflammation in Traf2EKO mice. Constitutive activation of non-canonical NF-542 
κB in Traf2EKOTnf-/- mice might however be responsible for the later onset skin disease that 543 
developed in these Tnf deficient mice (Figure 11). To test this, we deleted both Tnf and 544 
Nfkb2 which completely rescued the skin inflammation in Traf2EKO mice. These data 545 
provide insights into the mechanism of initiation and development of inflammatory skin 546 
disease that may be important to further understanding of diseases such as psoriasis. 547 
Moreover, our findings provide further evidence that TNF-induced apoptosis can play a 548 
role in inflammatory skin disease and indicate that defects in keratinocytes themselves can 549 
initiate TNF-dependent and independent inflammation. Importantly, we have shown that 550 
non-canonical NF-κB signalling can be the driver of inflammation in epithelial cells. This 551 
observation might be relevant to human psoriasis because it has been reported that the 552 
levels of TWEAK and its receptor Fn-14 are elevated in human psoriatic lesions (Cheng et 553 
al., 2015) and it is well established that TWEAK/Fn14 signalling induces degradation of 554 
TRAF2 and activation of non-canonical NF-κB signalling (Saitoh et al., 2003; Vince et al., 555 
2008). Thus, our results suggest that inhibition of non-canonical NF-κB signalling might 556 
be beneficial in chronic inflammatory disease together with TNF inhibitors. 557 
Materials and methods 558 
Mice 559 
Mice were maintained at the Walter and Eliza Hall Institute (WEHI) under the approval of 560 
WEHI ethics committee. Animal technicians performed unbiased mouse monitoring and 561 
informed us if mice developed skin inflammation and needed to be sacrificed according to 562 
the WEHI animal ethic guidelines. 563 
 564 
Immunobloting 565 
Cell lysates were prepared using DISC buffer (1% NP-40, 10% glycerol, 150 mM NaCl, 566 
20 mM Tris pH 7.5, 2 mM EDTA, Roche cOmpleteTM protease inhibitor cocktail, 2 mM 567 
sodium orthovanadate, 10 mM sodium fluoride, β-glycerophosphate, N2O2PO7). Cell 568 
lysates were loaded on NuPAGE Bis-Tris gels (Life Technologies) and transferred on to 569 
Immobilon-P PVDF membranes (Millipore) or Hybond-C Extra (GE Healthcare). 570 
Membranes were blocked and antibodies diluted in 5% skim milk powder or Bovine 571 
Serum Albumin (BSA) in 0.1% Tween20 in PBS or TBS. Antibodies used for Western blot 572 
were: Cleaved caspase-3 (9661) and -8 (8592), phospho-JNK1/2 (4668P), phospho-p38 573 
(4511), p38 (9212), caspase-8 (4927), JNK1/2 (9252), IκBα (CN: 9242) and phospho-p65 574 
(3033) from Cell Signaling Technology, β-actin (A-1978; Sigma Aldrich), cFLIP (AG-575 
20B-0005; Adipogen), RIPK1 (610458; BD Transduction Laboratories) and VDAC1 576 
(AB10547; Millipore). Monoclonal antibody for TRAF2 was made in house and raised 577 
against the RING domain of TRAF2 (Clone: 6/12-2D1-22-1). cIAP1 antibody was made in 578 
house and is distributed by ENZO (1E1-1-10). MLKL antibody was made in house as 579 
described (Murphy et al., 2013). Signals were detected by chemiluminescence (Millipore) 580 
after incubation with secondary antibodies conjugated to HRP. 581 
 582 
Immuno precipitation of ubiquitin-conjugates (TUBE IP) 583 
Tandem Ubiquitin Binding Entities (TUBE1: binds to K6-, K11-, K48- and K63-linked 584 
polyubiquitin, Lifesensors) beads were used to purify ubiquitin conjugates from MDFs 585 
according to the manufacturer’s recommendations (Hjerpe et al., 2009). Wild–type, Traf2-/- 586 
and Sphk1-/- immortalised MDFs were treated with TNF (100 ng/ml) for the times indicated 587 
and lysed in ice-cold DISC buffer. The lysates were incubated with TUBE beads for 2 hours 588 
at 4oC before washing 3x in ice-cold PBS-Tween. Washed beads were resuspended in 1x SDS 589 
sample buffer, separated on SDS-PAGE gels and subjected to Western Blotting and probed 590 
with the indicated antibodies. 591 
 592 
Histology and immunofluorescence 593 
Skin samples were fixed in 10% neutral buffered formalin, paraffin embedded, and 594 
sectioned for routine histology staining (H&E). For skin immunofluorescence, parafin 595 
sections were dewaxed, subjected to heat-induced epitope retrieval (HIER) with citrate 596 
buffer, blocked in 3% goat serum, then permeabilised with 0.3% Triton X-100, and stained 597 
with keratin 6 (Covance) or keratin 14, and goat anti-rabbit alexa-594 (Invitrogen) 598 
antibodies. Nuclei were visualized using Hoechst (Invitrogen). For tissue 599 
immunohistochemistry, sections were dewaxed and subjected to antigen retrieval in trypsin 600 
buffer or HIER with citrate buffer and stained with anti-CC3 (Cell Signaling Technology 601 
9661), anti-CD45 (BD) and goat anti-rabbit biotinylated antibodies. Images were taken 602 
using a DP72 microscope and cellSens Standard software (Olympus). 603 
 604 
Isolation of cells from skin and cytokine measurement 605 
Skin was separated from the tail of an adult mouse and incubated in dispase II (20 mg/ml) 606 
at 4˚C for 24 hours and keratinocytes and MDFs were isolated from the epidermal and 607 
dermal layers respectively as described before (Etemadi et al., 2013; Rickard, Anderton, et 608 
al., 2014) TNF ELISA was performed using (eBioscience, 88-7324) kit following the 609 
manufacturer's protocol. 610 
 611 
qPCR inflammation array 612 
Cultured keratinocytes in one well of a 6-well plate were lysed in 500 μl TRIzol 613 
(Invitrogen) and the RNA was purified using PureLink RNA purification kit (Ambion). 614 
cDNA was made with SuperScript VILO cDNA Synthesis kit (Invitrogen) and qPCR was 615 
performed using TaqMan Open Array mouse inflammation panel (Applied Biosystems) on 616 
a QuantStudio 12K Flex machine (life technologies) following the manufacturer protocols. 617 
 618 
Statistical analyses of qPCR inflammation array data 619 
Ct values were exported from Life Science’s Expression Suite software and statistical analysis 620 
was undertaken using the limma software package (Ritchie et al., 2015). The maximum 621 
measurable Ct value was 40, so Ct values were transformed to a log2 expression scale by 622 
subtracting the Ct values from 41. The expression values were normalized using cyclic loess 623 
normalization (Bolstad, Irizarry, Astrand, & Speed, 2003) with house-keeping probes up-624 
weighted 10-fold. The cyclic method was set to “affy”, the loess span was 0.7 and 3 cyclic 625 
iterations were used. The probes Gapdh, Pgk, Hmbs, Hprt and Ppia are treated as house-626 
keeping. Probes were filtered out as unexpressed if they failed to achieve a normalized value 627 
of 4 in at least 3 samples. Comparisons were made between Traf2-/-Tnf-/- and Traf2+/-Tnf-/- 628 
keratinocytes using empirical Bayes t-statistics (Smyth, 2004). The empirical Bayes hyper-629 
parameters were estimated robustly including an abundance-dependent trend. The false 630 
discovery rate (FDR) was controlled below 0.05 using the method of Benjamini and 631 
Hochberg (Benjamini & Hochberg, 1995).  632 
 633 
Cell death and viability assay 634 
Cells were harvested after 24h treatment with human Fc-TNF (made in house, referred as 635 
“TNF” in the manuscript) and Smac-mimetic (TetraLogic) and cell death was measured by 636 
Propidium Iodide (PI) staining and flow cytometry performed on a FACSCalibur flow 637 
cytometer (BD Biosciences) and analysed using Weasel (WEHI). Keratinocyte viability 638 
was assayed using CellTiter 96 (Promega) according to the manufacturer’s instructions. 639 
 640 
Skin digestion and flow cytometry 641 
Epidermal and dermal layers of ears were separated after 30 min incubation with 2.4 U/ml 642 
Dispase (Gibco) at 37°C, followed by cutting into fine pieces and digested with 50 U/ml 643 
collagenase for 45 min at 37°C. Single cell suspension was made in FACS buffer (PBS, 644 
0.5% BSA; Sigma Aldrich) and blocked with Fc block (eBioscience) and stained with the 645 
following antibodies in FACS buffer at 4°C as described before (Chopin et al., 2013). 646 
Antibodies raised against CD11c (N418), CD45.2 (A20), MHCII (M514.15.2), CD8α 647 
(53-6.7), CD4 (GK1.4), IFNγ, Ly6G (1A8), were purchased from BD biosciences. TCRβ 648 
(H57-597) and cd11b (M1/70) were purchased from eBioscience. 649 
 650 
T cell stimulation 651 
Dermal T cells were isolated from the skin and resuspended in RPMI-1640 supplemented 652 
with 10% heat inactivated fetal calf serum, 2mM L-Glutamine (GIBCO), 50 μM 2-653 
mercaptoethanol (Sigma) 100 U/ml penicillin/streptomycin (GIBCO). Cells were 654 
stimulated for 4 hours in presence of PMA (20ng/ml) and Ionomycin (1μg/ml) in presence 655 
of the GolgiPlug (BD Biosciences). 656 
 657 
Reconstitution experiments 658 
Mice were irradiated with 550 rads twice with three hours minimum between irradiation. 659 
Approximately 5 million cells from the bone marrow of C57/BL6 or IFNγ mice were 660 
injected by tail i.v. to Traf2EKO Mice were maintained on 2mg/ml neomycin in drinking 661 
water for three weeks post irradiation. 662 
 663 
Fractionation and Blue-Native PAGE 664 
Stimulated keratinocytes were permeabilised in buffer containing 0.025% digitonin. 665 
Cytosolic and crude membrane fractions were further solubilized in 1% digitonin, resolved 666 
by Bis·Tris Native PAGE as described before (Hildebrand et al., 2014), and immuno-667 
probed for MLKL. 668 
 669 
Acknowledgements 670 
We thank staff in the WEHI Bioservices facility, Heinrich Korner for Tnf -/- mice, James 671 
Murphy and Warren Alexander for Ifng-/- and Mlkl-/-, Robert Brink for Traf2lox/lox and 672 
Roland Schmid for Nfkb2-/- mice. This work was supported by NHMRC grants (1025594, 673 
1046984, 1048278, 546272), NHMRC fellowships to JS (541901, 1058190), SLN 674 
(1058238), NIH grants (HL67330 and CA77839 TH), SNSF project grant (310030-675 
138085) and the Thomas William and Violet Coles Trust Fund with additional Victorian 676 
State Government Operational Infrastructure Support, NHMRC IRIISS grant (361646). 677 
We thank George Varigos for discussions and support. 678 
 679 
Conflict of Interest 680 
The authors declare no conflict of interest. 681 
 682 
References 683 
 684 
Adada, M. M., Orr-Gandy, K. A., Snider, A. J., Canals, D., Hannun, Y. A., Obeid, L. M., & Clarke, 685 
C. J. (2013). Sphingosine kinase 1 regulates tumor necrosis factor-mediated RANTES 686 
induction through p38 mitogen-activated protein kinase but independently of nuclear factor 687 
kappaB activation. J Biol Chem, 288(38), 27667-27679. doi: 10.1074/jbc.M113.489443 688 
Allende, M. L., Sasaki, T., Kawai, H., Olivera, A., Mi, Y., van Echten-Deckert, G., Hajdu, R., 689 
Rosenbach, M., Keohane, C. A., Mandala, S., Spiegel, S., & Proia, R. L. (2004). Mice 690 
deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J Biol Chem, 691 
279(50), 52487-52492. doi: 10.1074/jbc.M406512200 692 
Alvarez, S. E., Harikumar, K. B., Hait, N. C., Allegood, J., Strub, G. M., Kim, E. Y., Maceyka, M., 693 
Jiang, H., Luo, C., Kordula, T., Milstien, S., & Spiegel, S. (2010). Sphingosine-1-phosphate 694 
is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature, 465(7301), 1084-1088. doi: 695 
10.1038/nature09128 696 
Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: a practical and 697 
powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B 57, 698 
289-300.  699 
Blackwell, K., Zhang, L., Workman, L. M., Ting, A. T., Iwai, K., & Habelhah, H. (2013). Two 700 
coordinated mechanisms underlie tumor necrosis factor alpha-induced immediate and 701 
delayed IkappaB kinase activation. Mol Cell Biol, 33(10), 1901-1915. doi: 702 
10.1128/MCB.01416-12 703 
Bolstad, B. M., Irizarry, R. A., Astrand, M., & Speed, T. P. (2003). A comparison of normalization 704 
methods for high density oligonucleotide array data based on variance and bias. 705 
Bioinformatics, 19(2), 185-193.  706 
Bonnet, M. C., Preukschat, D., Welz, P. S., van Loo, G., Ermolaeva, M. A., Bloch, W., Haase, I., & 707 
Pasparakis, M. (2011). The adaptor protein FADD protects epidermal keratinocytes from 708 
necroptosis in vivo and prevents skin inflammation. Immunity, 35(4), 572-582. doi: 709 
10.1016/j.immuni.2011.08.014 710 
Cheng, H., Xu, M., Liu, X., Zou, X., Zhan, N., & Xia, Y. (2015). TWEAK/Fn14 activation induces 711 
keratinocyte proliferation under psoriatic inflammation. Exp Dermatol. doi: 712 
10.1111/exd.12820 713 
Chipuk, J. E., McStay, G. P., Bharti, A., Kuwana, T., Clarke, C. J., Siskind, L. J., Obeid, L. M., & 714 
Green, D. R. (2012). Sphingolipid metabolism cooperates with BAK and BAX to promote 715 
the mitochondrial pathway of apoptosis. Cell, 148(5), 988-1000. doi: 716 
10.1016/j.cell.2012.01.038 717 
Chopin, M., Seillet, C., Chevrier, S., Wu, L., Wang, H., Morse, H. C., 3rd, Belz, G. T., & Nutt, S. 718 
L. (2013). Langerhans cells are generated by two distinct PU.1-dependent transcriptional 719 
networks. J Exp Med, 210(13), 2967-2980. doi: 10.1084/jem.20130930 720 
Dannappel, M., Vlantis, K., Kumari, S., Polykratis, A., Kim, C., Wachsmuth, L., Eftychi, C., Lin, 721 
J., Corona, T., Hermance, N., Zelic, M., Kirsch, P., Basic, M., Bleich, A., Kelliher, M., & 722 
Pasparakis, M. (2014). RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and 723 
necroptosis. Nature, 513(7516), 90-94. doi: 10.1038/nature13608 724 
Dillon, C. P., Weinlich, R., Rodriguez, D. A., Cripps, J. G., Quarato, G., Gurung, P., Verbist, K. C., 725 
Brewer, T. L., Llambi, F., Gong, Y. N., Janke, L. J., Kelliher, M. A., Kanneganti, T. D., & 726 
Green, D. R. (2014). RIPK1 blocks early postnatal lethality mediated by caspase-8 and 727 
RIPK3. Cell, 157(5), 1189-1202. doi: 10.1016/j.cell.2014.04.018 728 
Dynek, J. N., Goncharov, T., Dueber, E. C., Fedorova, A. V., Izrael-Tomasevic, A., Phu, L., 729 
Helgason, E., Fairbrother, W. J., Deshayes, K., Kirkpatrick, D. S., & Vucic, D. (2010). c-730 
IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO 731 
J, 29(24), 4198-4209. doi: 10.1038/emboj.2010.300 732 
Etemadi, N., Holien, J. K., Chau, D., Dewson, G., Murphy, J. M., Alexander, W. S., Parker, M. W., 733 
Silke, J., & Nachbur, U. (2013). Lymphotoxin alpha induces apoptosis, necroptosis and 734 
inflammatory signals with the same potency as tumour necrosis factor. FEBS J, 280(21), 735 
5283-5297. doi: 10.1111/febs.12419 736 
Gardam, S., Sierro, F., Basten, A., Mackay, F., & Brink, R. (2008). TRAF2 and TRAF3 signal 737 
adapters act cooperatively to control the maturation and survival signals delivered to B cells 738 
by the BAFF receptor. Immunity, 28(3), 391-401. doi: 10.1016/j.immuni.2008.01.009 739 
Gerlach, B., Cordier, S. M., Schmukle, A. C., Emmerich, C. H., Rieser, E., Haas, T. L., Webb, A. I., 740 
Rickard, J. A., Anderton, H., Wong, W. W., Nachbur, U., Gangoda, L., Warnken, U., 741 
Purcell, A. W., Silke, J., & Walczak, H. (2011). Linear ubiquitination prevents inflammation 742 
and regulates immune signalling. Nature, 471(7340), 591-596. doi: 10.1038/nature09816 743 
Gonzalvez, F., Lawrence, D., Yang, B., Yee, S., Pitti, R., Marsters, S., Pham, V. C., Stephan, J. P., 744 
Lill, J., & Ashkenazi, A. (2012). TRAF2 Sets a threshold for extrinsic apoptosis by tagging 745 
caspase-8 with a ubiquitin shutoff timer. Mol Cell, 48(6), 888-899. doi: 746 
10.1016/j.molcel.2012.09.031 747 
Grech, A. P., Amesbury, M., Chan, T., Gardam, S., Basten, A., & Brink, R. (2004). TRAF2 748 
differentially regulates the canonical and noncanonical pathways of NF-kappaB activation 749 
in mature B cells. Immunity, 21(5), 629-642. doi: 10.1016/j.immuni.2004.09.011 750 
Gudjonsson, J. E., Johnston, A., Dyson, M., Valdimarsson, H., & Elder, J. T. (2007). Mouse models 751 
of psoriasis. J Invest Dermatol, 127(6), 1292-1308. doi: 10.1038/sj.jid.5700807 752 
Ha, H. L., Wang, H., Pisitkun, P., Kim, J. C., Tassi, I., Tang, W., Morasso, M. I., Udey, M. C., & 753 
Siebenlist, U. (2014). IL-17 drives psoriatic inflammation via distinct, target cell-specific 754 
mechanisms. Proc Natl Acad Sci U S A, 111(33), E3422-3431. doi: 755 
10.1073/pnas.1400513111 756 
Haas, T. L., Emmerich, C. H., Gerlach, B., Schmukle, A. C., Cordier, S. M., Rieser, E., Feltham, R., 757 
Vince, J., Warnken, U., Wenger, T., Koschny, R., Komander, D., Silke, J., & Walczak, H. 758 
(2009). Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 759 
signaling complex and is required for TNF-mediated gene induction. Mol Cell, 36(5), 831-760 
844. doi: 10.1016/j.molcel.2009.10.013 761 
Hait, N. C., Allegood, J., Maceyka, M., Strub, G. M., Harikumar, K. B., Singh, S. K., Luo, C., 762 
Marmorstein, R., Kordula, T., Milstien, S., & Spiegel, S. (2009). Regulation of histone 763 
acetylation in the nucleus by sphingosine-1-phosphate. Science, 325(5945), 1254-1257. doi: 764 
10.1126/science.1176709 765 
Hildebrand, J. M., Tanzer, M. C., Lucet, I. S., Young, S. N., Spall, S. K., Sharma, P., Pierotti, C., 766 
Garnier, J. M., Dobson, R. C., Webb, A. I., Tripaydonis, A., Babon, J. J., Mulcair, M. D., 767 
Scanlon, M. J., Alexander, W. S., Wilks, A. F., Czabotar, P. E., Lessene, G., Murphy, J. M., 768 
& Silke, J. (2014). Activation of the pseudokinase MLKL unleashes the four-helix bundle 769 
domain to induce membrane localization and necroptotic cell death. Proc Natl Acad Sci U S 770 
A, 111(42), 15072-15077. doi: 10.1073/pnas.1408987111 771 
Hjerpe, R., Aillet, F., Lopitz-Otsoa, F., Lang, V., England, P., & Rodriguez, M. S. (2009). Efficient 772 
protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. 773 
EMBO Rep, 10(11), 1250-1258. doi: 10.1038/embor.2009.192 774 
Hla, T., & Dannenberg, A. J. (2012). Sphingolipid signaling in metabolic disorders. Cell Metab, 775 
16(4), 420-434. doi: 10.1016/j.cmet.2012.06.017 776 
Hostager, B. S., Haxhinasto, S. A., Rowland, S. L., & Bishop, G. A. (2003). Tumor necrosis factor 777 
receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for 778 
TRAF2 in CD40 signaling. J Biol Chem, 278(46), 45382-45390. doi: 779 
10.1074/jbc.M306708200 780 
Jabara, H., Laouini, D., Tsitsikov, E., Mizoguchi, E., Bhan, A., Castigli, E., Dedeoglu, F., Pivniouk, 781 
V., Brodeur, S., & Geha, R. (2002). The binding site for TRAF2 and TRAF3 but not for 782 
TRAF6 is essential for CD40-mediated immunoglobulin class switching. Immunity, 17(3), 783 
265-276.  784 
Kohama, T., Olivera, A., Edsall, L., Nagiec, M. M., Dickson, R., & Spiegel, S. (1998). Molecular 785 
cloning and functional characterization of murine sphingosine kinase. J Biol Chem, 273(37), 786 
23722-23728.  787 
Kovalenko, A., Kim, J. C., Kang, T. B., Rajput, A., Bogdanov, K., Dittrich-Breiholz, O., Kracht, 788 
M., Brenner, O., & Wallach, D. (2009). Caspase-8 deficiency in epidermal keratinocytes 789 
triggers an inflammatory skin disease. J Exp Med, 206(10), 2161-2177. doi: 790 
10.1084/jem.20090616 791 
Kumari, S., Redouane, Y., Lopez-Mosqueda, J., Shiraishi, R., Romanowska, M., Lutzmayer, S., 792 
Kuiper, J., Martinez, C., Dikic, I., Pasparakis, M., & Ikeda, F. (2014). Sharpin prevents skin 793 
inflammation by inhibiting TNFR1-induced keratinocyte apoptosis. Elife, 3. doi: 794 
10.7554/eLife.03422 795 
Lee, S. Y., Reichlin, A., Santana, A., Sokol, K. A., Nussenzweig, M. C., & Choi, Y. (1997). TRAF2 796 
is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation 797 
and survival. Immunity, 7(5), 703-713.  798 
Lin, W. J., Su, Y. W., Lu, Y. C., Hao, Z., Chio, II, Chen, N. J., Brustle, A., Li, W. Y., & Mak, T. 799 
W. (2011). Crucial role for TNF receptor-associated factor 2 (TRAF2) in regulating 800 
NFkappaB2 signaling that contributes to autoimmunity. Proc Natl Acad Sci U S A, 108(45), 801 
18354-18359. doi: 10.1073/pnas.1109427108 802 
Liu, H., Sugiura, M., Nava, V. E., Edsall, L. C., Kono, K., Poulton, S., Milstien, S., Kohama, T., & 803 
Spiegel, S. (2000). Molecular cloning and functional characterization of a novel mammalian 804 
sphingosine kinase type 2 isoform. J Biol Chem, 275(26), 19513-19520. doi: 805 
10.1074/jbc.M002759200 806 
Mahoney, D. J., Cheung, H. H., Mrad, R. L., Plenchette, S., Simard, C., Enwere, E., Arora, V., 807 
Mak, T. W., Lacasse, E. C., Waring, J., & Korneluk, R. G. (2008). Both cIAP1 and cIAP2 808 
regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci U S A, 105(33), 809 
11778-11783. doi: 10.1073/pnas.0711122105 810 
Murphy, J. M., Czabotar, P. E., Hildebrand, J. M., Lucet, I. S., Zhang, J. G., Alvarez-Diaz, S., 811 
Lewis, R., Lalaoui, N., Metcalf, D., Webb, A. I., Young, S. N., Varghese, L. N., Tannahill, 812 
G. M., Hatchell, E. C., Majewski, I. J., Okamoto, T., Dobson, R. C., Hilton, D. J., Babon, J. 813 
J., Nicola, N. A., Strasser, A., Silke, J., & Alexander, W. S. (2013). The pseudokinase 814 
MLKL mediates necroptosis via a molecular switch mechanism. Immunity, 39(3), 443-453. 815 
doi: 10.1016/j.immuni.2013.06.018 816 
Nair, R. P., Duffin, K. C., Helms, C., Ding, J., Stuart, P. E., Goldgar, D., Gudjonsson, J. E., Li, Y., 817 
Tejasvi, T., Feng, B. J., Ruether, A., Schreiber, S., Weichenthal, M., Gladman, D., Rahman, 818 
P., Schrodi, S. J., Prahalad, S., Guthery, S. L., Fischer, J., Liao, W., Kwok, P. Y., Menter, 819 
A., Lathrop, G. M., Wise, C. A., Begovich, A. B., Voorhees, J. J., Elder, J. T., Krueger, G. 820 
G., Bowcock, A. M., Abecasis, G. R., & Collaborative Association Study of, P. (2009). 821 
Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. 822 
Nat Genet, 41(2), 199-204. doi: 10.1038/ng.311 823 
Nenci, A., Huth, M., Funteh, A., Schmidt-Supprian, M., Bloch, W., Metzger, D., Chambon, P., 824 
Rajewsky, K., Krieg, T., Haase, I., & Pasparakis, M. (2006). Skin lesion development in a 825 
mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal 826 
keratinocytes and requires TNF signaling. Hum Mol Genet, 15(4), 531-542. doi: 827 
10.1093/hmg/ddi470 828 
Nestle, F. O., Di Meglio, P., Qin, J. Z., & Nickoloff, B. J. (2009). Skin immune sentinels in health 829 
and disease. Nat Rev Immunol, 9(10), 679-691. doi: 10.1038/nri2622 830 
Neubauer, H. A., & Pitson, S. M. (2013). Roles, regulation and inhibitors of sphingosine kinase 2. 831 
FEBS J, 280(21), 5317-5336. doi: 10.1111/febs.12314 832 
Panayotova-Dimitrova, D., Feoktistova, M., Ploesser, M., Kellert, B., Hupe, M., Horn, S., Makarov, 833 
R., Jensen, F., Porubsky, S., Schmieder, A., Zenclussen, A. C., Marx, A., Kerstan, A., 834 
Geserick, P., He, Y. W., & Leverkus, M. (2013). cFLIP regulates skin homeostasis and 835 
protects against TNF-induced keratinocyte apoptosis. Cell Rep, 5(2), 397-408. doi: 836 
10.1016/j.celrep.2013.09.035 837 
Pasparakis, M., Courtois, G., Hafner, M., Schmidt-Supprian, M., Nenci, A., Toksoy, A., Krampert, 838 
M., Goebeler, M., Gillitzer, R., Israel, A., Krieg, T., Rajewsky, K., & Haase, I. (2002). 839 
TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. 840 
Nature, 417(6891), 861-866. doi: 10.1038/nature00820 841 
Pasparakis, M., & Vandenabeele, P. (2015). Necroptosis and its role in inflammation. Nature, 842 
517(7534), 311-320. doi: 10.1038/nature14191 843 
Petersen, S. L., Chen, T. T., Lawrence, D. A., Marsters, S. A., Gonzalvez, F., & Ashkenazi, A. 844 
(2015). TRAF2 is a biologically important necroptosis suppressor. Cell Death Differ. doi: 845 
10.1038/cdd.2015.35 846 
Piao, J. H., Hasegawa, M., Heissig, B., Hattori, K., Takeda, K., Iwakura, Y., Okumura, K., Inohara, 847 
N., & Nakano, H. (2011). Tumor necrosis factor receptor-associated factor (TRAF) 2 848 
controls homeostasis of the colon to prevent spontaneous development of murine 849 
inflammatory bowel disease. J Biol Chem, 286(20), 17879-17888. doi: 850 
10.1074/jbc.M111.221853 851 
Pitson, S. M. (2011). Regulation of sphingosine kinase and sphingolipid signaling. Trends Biochem 852 
Sci, 36(2), 97-107. doi: 10.1016/j.tibs.2010.08.001 853 
Poon, I. K., Chiu, Y. H., Armstrong, A. J., Kinchen, J. M., Juncadella, I. J., Bayliss, D. A., & 854 
Ravichandran, K. S. (2014). Unexpected link between an antibiotic, pannexin channels and 855 
apoptosis. Nature, 507(7492), 329-334. doi: 10.1038/nature13147 856 
Qian, Y., Liu, C., Hartupee, J., Altuntas, C. Z., Gulen, M. F., Jane-Wit, D., Xiao, J., Lu, Y., Giltiay, 857 
N., Liu, J., Kordula, T., Zhang, Q. W., Vallance, B., Swaidani, S., Aronica, M., Tuohy, V. 858 
K., Hamilton, T., & Li, X. (2007). The adaptor Act1 is required for interleukin 17-dependent 859 
signaling associated with autoimmune and inflammatory disease. Nat Immunol, 8(3), 247-860 
256. doi: 10.1038/ni1439 861 
Rickard, J. A., Anderton, H., Etemadi, N., Nachbur, U., Darding, M., Peltzer, N., Lalaoui, N., 862 
Lawlor, K. E., Vanyai, H., Hall, C., Bankovacki, A., Gangoda, L., Wong, W. W., Corbin, J., 863 
Huang, C., Mocarski, E. S., Murphy, J. M., Alexander, W. S., Voss, A. K., Vaux, D. L., 864 
Kaiser, W. J., Walczak, H., & Silke, J. (2014). TNFR1-dependent cell death drives 865 
inflammation in Sharpin-deficient mice. Elife, 3. doi: 10.7554/eLife.03464 866 
Rickard, J. A., O'Donnell, J. A., Evans, J. M., Lalaoui, N., Poh, A. R., Rogers, T., Vince, J. E., 867 
Lawlor, K. E., Ninnis, R. L., Anderton, H., Hall, C., Spall, S. K., Phesse, T. J., Abud, H. E., 868 
Cengia, L. H., Corbin, J., Mifsud, S., Di Rago, L., Metcalf, D., Ernst, M., Dewson, G., 869 
Roberts, A. W., Alexander, W. S., Murphy, J. M., Ekert, P. G., Masters, S. L., Vaux, D. L., 870 
Croker, B. A., Gerlic, M., & Silke, J. (2014). RIPK1 regulates RIPK3-MLKL-driven 871 
systemic inflammation and emergency hematopoiesis. Cell, 157(5), 1175-1188. doi: 872 
10.1016/j.cell.2014.04.019 873 
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015). limma 874 
powers differential expression analyses for RNA-sequencing and microarray studies. 875 
Nucleic Acids Res, 43(7), e47. doi: 10.1093/nar/gkv007 876 
Rothe, M., Wong, S. C., Henzel, W. J., & Goeddel, D. V. (1994). A novel family of putative signal 877 
transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor 878 
receptor. Cell, 78(4), 681-692.  879 
Saitoh, T., Nakayama, M., Nakano, H., Yagita, H., Yamamoto, N., & Yamaoka, S. (2003). 880 
TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation. J 881 
Biol Chem, 278(38), 36005-36012. doi: 10.1074/jbc.M304266200 882 
Shi, C. S., & Kehrl, J. H. (2003). Tumor necrosis factor (TNF)-induced germinal center kinase-883 
related (GCKR) and stress-activated protein kinase (SAPK) activation depends upon the 884 
E2/E3 complex Ubc13-Uev1A/TNF receptor-associated factor 2 (TRAF2). J Biol Chem, 885 
278(17), 15429-15434. doi: 10.1074/jbc.M211796200 886 
Shinkura, R., Matsuda, F., Sakiyama, T., Tsubata, T., Hiai, H., Paumen, M., Miyawaki, S., & 887 
Honjo, T. (1996). Defects of somatic hypermutation and class switching in alymphoplasia 888 
(aly) mutant mice. Int Immunol, 8(7), 1067-1075.  889 
Shu, H. B., Takeuchi, M., & Goeddel, D. V. (1996). The tumor necrosis factor receptor 2 signal 890 
transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 891 
signaling complex. Proc Natl Acad Sci U S A, 93(24), 13973-13978.  892 
Silke, J. (2011). The regulation of TNF signalling: what a tangled web we weave. Curr Opin 893 
Immunol, 23(5), 620-626. doi: 10.1016/j.coi.2011.08.002 894 
Silke, J., & Brink, R. (2010). Regulation of TNFRSF and innate immune signalling complexes by 895 
TRAFs and cIAPs. Cell Death Differ, 17(1), 35-45. doi: 10.1038/cdd.2009.114 896 
Smyth, G. K. (2004). Linear models and empirical bayes methods for assessing differential 897 
expression in microarray experiments. Stat Appl Genet Mol Biol, 3(1), Article3.  898 
Spiegel, S., & Milstien, S. (2011). The outs and the ins of sphingosine-1-phosphate in immunity. 899 
Nat Rev Immunol, 11(6), 403-415. doi: 10.1038/nri2974 900 
Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., & 901 
Wang, X. (2012). Mixed lineage kinase domain-like protein mediates necrosis signaling 902 
downstream of RIP3 kinase. Cell, 148(1-2), 213-227. doi: 10.1016/j.cell.2011.11.031 903 
Tada, K., Okazaki, T., Sakon, S., Kobarai, T., Kurosawa, K., Yamaoka, S., Hashimoto, H., Mak, T. 904 
W., Yagita, H., Okumura, K., Yeh, W. C., & Nakano, H. (2001). Critical roles of TRAF2 905 
and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from 906 
cell death. J Biol Chem, 276(39), 36530-36534. doi: 10.1074/jbc.M104837200 907 
Takeuchi, M., Rothe, M., & Goeddel, D. V. (1996). Anatomy of TRAF2. Distinct domains for 908 
nuclear factor-kappaB activation and association with tumor necrosis factor signaling 909 
proteins. J Biol Chem, 271(33), 19935-19942.  910 
Tse, M. T. (2013). IL-17 antibodies gain momentum. Nat Rev Drug Discov, 12(11), 815-816. doi: 911 
10.1038/nrd4152 912 
Uhlen, M., Fagerberg, L., Hallstrom, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, 913 
A., Kampf, C., Sjostedt, E., Asplund, A., Olsson, I., Edlund, K., Lundberg, E., Navani, S., 914 
Szigyarto, C. A., Odeberg, J., Djureinovic, D., Takanen, J. O., Hober, S., Alm, T., Edqvist, 915 
P. H., Berling, H., Tegel, H., Mulder, J., Rockberg, J., Nilsson, P., Schwenk, J. M., 916 
Hamsten, M., von Feilitzen, K., Forsberg, M., Persson, L., Johansson, F., Zwahlen, M., von 917 
Heijne, G., Nielsen, J., & Ponten, F. (2015). Proteomics. Tissue-based map of the human 918 
proteome. Science, 347(6220), 1260419. doi: 10.1126/science.1260419 919 
Uren, A. G., & Vaux, D. L. (1996). TRAF proteins and meprins share a conserved domain. Trends 920 
Biochem Sci, 21(7), 244-245.  921 
Vallabhapurapu, S., Matsuzawa, A., Zhang, W., Tseng, P. H., Keats, J. J., Wang, H., Vignali, D. A., 922 
Bergsagel, P. L., & Karin, M. (2008). Nonredundant and complementary functions of 923 
TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative 924 
NF-kappaB signaling. Nat Immunol, 9(12), 1364-1370. doi: 10.1038/ni.1678 925 
van Nieuwenhuijze, A., Koenders, M., Roeleveld, D., Sleeman, M. A., van den Berg, W., & Wicks, 926 
I. P. (2013). GM-CSF as a therapeutic target in inflammatory diseases. Mol Immunol, 56(4), 927 
675-682. doi: 10.1016/j.molimm.2013.05.002 928 
Varfolomeev, E., Goncharov, T., Fedorova, A. V., Dynek, J. N., Zobel, K., Deshayes, K., 929 
Fairbrother, W. J., & Vucic, D. (2008). c-IAP1 and c-IAP2 are critical mediators of tumor 930 
necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J Biol Chem, 283(36), 931 
24295-24299. doi: 10.1074/jbc.C800128200 932 
Vince, J. E., Chau, D., Callus, B., Wong, W. W., Hawkins, C. J., Schneider, P., McKinlay, M., 933 
Benetatos, C. A., Condon, S. M., Chunduru, S. K., Yeoh, G., Brink, R., Vaux, D. L., & 934 
Silke, J. (2008). TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-935 
TRAF2 complex to sensitize tumor cells to TNFalpha. J Cell Biol, 182(1), 171-184. doi: 936 
10.1083/jcb.200801010 937 
Vince, J. E., Pantaki, D., Feltham, R., Mace, P. D., Cordier, S. M., Schmukle, A. C., Davidson, A. 938 
J., Callus, B. A., Wong, W. W., Gentle, I. E., Carter, H., Lee, E. F., Walczak, H., Day, C. L., 939 
Vaux, D. L., & Silke, J. (2009). TRAF2 must bind to cellular inhibitors of apoptosis for 940 
tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced 941 
apoptosis. J Biol Chem, 284(51), 35906-35915. doi: 10.1074/jbc.M109.072256 942 
Vince, J. E., Wong, W. W., Khan, N., Feltham, R., Chau, D., Ahmed, A. U., Benetatos, C. A., 943 
Chunduru, S. K., Condon, S. M., McKinlay, M., Brink, R., Leverkus, M., Tergaonkar, V., 944 
Schneider, P., Callus, B. A., Koentgen, F., Vaux, D. L., & Silke, J. (2007). IAP antagonists 945 
target cIAP1 to induce TNFalpha-dependent apoptosis. Cell, 131(4), 682-693. doi: 946 
10.1016/j.cell.2007.10.037 947 
Weinlich, R., Oberst, A., Dillon, C. P., Janke, L. J., Milasta, S., Lukens, J. R., Rodriguez, D. A., 948 
Gurung, P., Savage, C., Kanneganti, T. D., & Green, D. R. (2013). Protective roles for 949 
caspase-8 and cFLIP in adult homeostasis. Cell Rep, 5(2), 340-348. doi: 950 
10.1016/j.celrep.2013.08.045 951 
Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., 952 
Baker, R., Boone, D. L., Ma, A., Koonin, E. V., & Dixit, V. M. (2004). De-ubiquitination 953 
and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature, 954 
430(7000), 694-699. doi: 10.1038/nature02794 955 
Wong, W. W., Vince, J. E., Lalaoui, N., Lawlor, K. E., Chau, D., Bankovacki, A., Anderton, H., 956 
Metcalf, D., O'Reilly, L., Jost, P. J., Murphy, J. M., Alexander, W. S., Strasser, A., Vaux, D. 957 
L., & Silke, J. (2014). cIAPs and XIAP regulate myelopoiesis through cytokine production 958 
in an RIPK1- and RIPK3-dependent manner. Blood, 123(16), 2562-2572. doi: 959 
10.1182/blood-2013-06-510743 960 
Xiong, Y., Lee, H. J., Mariko, B., Lu, Y. C., Dannenberg, A. J., Haka, A. S., Maxfield, F. R., 961 
Camerer, E., Proia, R. L., & Hla, T. (2013). Sphingosine kinases are not required for 962 
inflammatory responses in macrophages. J Biol Chem, 288(45), 32563-32573. doi: 963 
10.1074/jbc.M113.483750 964 
Yeh, W. C., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J. L., 965 
Ferrick, D., Hum, B., Iscove, N., Ohashi, P., Rothe, M., Goeddel, D. V., & Mak, T. W. 966 
(1997). Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-967 
induced cell death in TRAF2-deficient mice. Immunity, 7(5), 715-725.  968 
Yin, L., Wu, L., Wesche, H., Arthur, C. D., White, J. M., Goeddel, D. V., & Schreiber, R. D. 969 
(2001). Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in 970 
NIK-deficient mice. Science, 291(5511), 2162-2165. doi: 10.1126/science.1058453 971 
Yin, Q., Lamothe, B., Darnay, B. G., & Wu, H. (2009). Structural basis for the lack of E2 972 
interaction in the RING domain of TRAF2. Biochemistry, 48(44), 10558-10567. doi: 973 
10.1021/bi901462e 974 
Yoshiki, R., Kabashima, K., Honda, T., Nakamizo, S., Sawada, Y., Sugita, K., Yoshioka, H., 975 
Ohmori, S., Malissen, B., Tokura, Y., & Nakamura, M. (2014). IL-23 from Langerhans cells 976 
is required for the development of imiquimod-induced psoriasis-like dermatitis by induction 977 
of IL-17A-producing gammadelta T cells. J Invest Dermatol, 134(7), 1912-1921. doi: 978 
10.1038/jid.2014.98 979 
Zarnegar, B. J., Wang, Y., Mahoney, D. J., Dempsey, P. W., Cheung, H. H., He, J., Shiba, T., Yang, 980 
X., Yeh, W. C., Mak, T. W., Korneluk, R. G., & Cheng, G. (2008). Noncanonical NF-981 
kappaB activation requires coordinated assembly of a regulatory complex of the adaptors 982 
cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat Immunol, 9(12), 1371-1378. 983 
doi: 10.1038/ni.1676 984 
Zhang, L., Blackwell, K., Shi, Z., & Habelhah, H. (2010). The RING domain of TRAF2 plays an 985 
essential role in the inhibition of TNFalpha-induced cell death but not in the activation of 986 
NF-kappaB. J Mol Biol, 396(3), 528-539. doi: 10.1016/j.jmb.2010.01.008 987 
Zhu, S., Pan, W., Shi, P., Gao, H., Zhao, F., Song, X., Liu, Y., Zhao, L., Li, X., Shi, Y., & Qian, Y. 988 
(2010). Modulation of experimental autoimmune encephalomyelitis through TRAF3-989 
mediated suppression of interleukin 17 receptor signaling. J Exp Med, 207(12), 2647-2662. 990 
doi: 10.1084/jem.20100703 991 
992 
Figures 993 
 994 
Figure 1. TRAF2 is not required for TNF-induced NF-κB and MAPK signalling in bone 995 
marrow derived macrophages. (A and B) Western blot analysis of wild type (WT), Traf2lox/lox 996 
Lyz2-Cre (Traf2LC) and Sphk1-/- BMDMs treated with TNF (20 ng/ml) for the indicated times. 997 
(C) FACS analysis of WT, Traf2LC BMDMs treated with TNF (20 ng/ml) ± 100 nM Smac-998 
mimetic (SM) for 24 hrs and stained with Propidium Iodide (PI) and analysed by flow cytometry. 999 
(D) WT, Traf2LC macrophages were treated with TNF (20 ng/ml) or Smac-mimetic (100 nM) for 1000 
indicated time and supernatants analysed by TNF ELISA. Data are represented as mean ± SEM. 1001 
 1002 
Figure 2. TRAF2 but not SPHK1 is required for TNF signalling in MEFs, MDFs and 1003 
keratinocytes. (A and B) Western blot analysis of wild type (WT), Traf2-/- and Sphk1-/- MEFs 1004 
and MDFs (as indicated) were treated with TNF (100 ng/ml) for the indicated times. (C) FACS 1005 
analysis of WT, Traf2-/- and Sphk1-/- MEFs and MDFs treated with TNF (100 ng/ml) for 24 hrs 1006 
and stained with Propidium Iodide (PI). n≥3 biological repeats. Data are represented as mean ± 1007 
SEM. (D) Western blot analysis of WT and Traf2-/- keratinocytes treated with TNF (100 ng/ml) 1008 
for the indicated times. (E) Western blot analysis of WT and Sphk1-/- keratinocytes treated with 1009 
TNF (100 ng/ml) for the indicated times. (F) WT, Traf2-/- and Sphk1-/- keratinocytes were treated 1010 
with TNF (100 ng/ml) for 24 hrs and metabolically active cells were measured by MTS-PMS 1011 
(MTS) assay. Biological repeats were WT and Traf2-/- (n=5) and Sphk1-/- (n=3). Data are 1012 
represented as mean ± SEM. P values compare the indicated samples using a Students t-test. 1013 
 1014 
Figure 3. TRAF2 but not SPHK1 is required for rapid, TNF-induced, RIPK1 1015 
ubiquitylation. (A and B) Wild type, Traf2-/- and Sphk1-/- MDFs were treated with TNF (100 1016 
ng/ml) for the indicated times. Cell lysates were prepared and precipitated with ubiquitin binding 1017 
TUBE beads then separated on an SDS/PAGE gel and Western blotted with the indicated 1018 
antibodies. 1019 
  1020 
Figure 4. Loss of TRAF2 in keratinocytes causes epidermal hyperplasia and psoriasis-like 1021 
inflammation. (A, B, D and E) Representative images and skin sections of the indicated mice 1022 
strains stained with haematoxylin/eosin (H&E), immuno-histochemistry for the pan leukocyte 1023 
marker (CD45) cleaved caspase-3 (CC3), or toluidine blue (TB), or immuno-stained for Keratin-1024 
14 or Keratin-16 (in red) plus Hoechst (nuclei in blue). Scale bars = 100μm. (C) The culture 1025 
media of primary keratinocytes of the indicated genotypes at 80% confluency was replaced with 1026 
serum free media which was collected 48 hours later and analysed with TNF ELISA. Biological 1027 
repeats WT (n=4) and Traf2-/- (n=5) are indicated. Data are represented as mean ± SEM. The 1028 
dashed line indicates minimum detectable range of the ELISA. P values compare the indicated 1029 
samples using a Students t-test. (F) Kaplan-Meier graph depicting survival of indicated mouse 1030 
strains. 1031 
 1032 
Figure 5. The early inflammation in Traf2EKO is caused by apoptosis in keratinocytes. (A 1033 
and B) Representative images and skin sections of indicated mice stained with 1034 
haematoxylin/eosin (H&E), toluidine blue (TB) or immuno-stained for Keratin-14 or Keratin-16 1035 
(in red) plus Hoechst (nuclei in blue). Scale bars = 100μm. (C) Traf2-/- and Sphk1-/- keratinocytes 1036 
were treated with TNF (100 ng/ml) for 5 hours in the absence or presence of QVD and/or Nec as 1037 
indicated. Cytoplasmic and Membrane (C & M) fractions were separated on a Blue Native 1038 
PAGE gel and Western blot with the indicated antibodies. (D) Traf2-/- keratinocytes were treated 1039 
with TNF (100 ng/ml) for 5 hours in the absence or presence of QVD or Nec as indicated. The 1040 
lysates were separated on an SDS/PAGE gel and Western blot with the indicated antibodies. 1041 
 1042 
Figure 6. Loss of TRAf2 in keratinocytes causes infiltration of neutrophils and IFNγ 1043 
producing CD4+ T cells to the skin. Single cell suspensions from mouse ears with skin 1044 
inflammation and healthy controls were prepared and the haematopoietic component (CD45.2+ 1045 
and PI- ) analysed by flow cytometry using the indicated markers. Representative contour plots 1046 
for Ly6G and CD11b staining in the epidermis (A) and dermis (C) of mice with indicated 1047 
genotype . Numbers indicate the proportion of CD11b+Ly6G+ neutrophils (boxed). Bar graph 1048 
showing percent infiltrated neutrophils to the epidermis (B) and dermis (D) n≥5, error bars are 1049 
SEM. (C) Representative contour plots for TCRβ and CD4 staining. Numbers indicate the 1050 
proportion of CD4+ T cells (boxed). (E) Representative contour plots for CD4 and TCRβ 1051 
staining in the dermis of mice with indicated genotype. (F) Bar graph showing the percent of 1052 
skin infiltrating CD4+ T cells, n≥8, error bars are SEM. (G) Bar graph showing percent of 1053 
infiltrating IFNγ producing CD4+ T cells to the dermis of mice indicated genotype, n≥5, data are 1054 
represented as mean ± SEM. Symbols in the graphs represent individual mice. All data are 1055 
relative to the total CD45+ and PI- cells. P values compare the indicated samples using a Students 1056 
t-test. 1057 
 1058 
Figure 7. Reconstitution with IFNγ bone marrow does not rescue the inflammation in 1059 
Traf2EKO mice. 6 week old Traf2EKO mice were lethally irradiated and injected with wild type 1060 
(wt) or Ifnγ-/- bone marrow cells. After 4 weeks of reconstitution (Recon.), all mice regardless of 1061 
the origin of injected cells started to develop inflammation similarly and needed to be sacrificed 1062 
by 8 weeks after reconstitution. (A) Representative images. (B) H&E staining of skin sections. 1063 
Scale bars = 100μm. 1064 
 1065 
Figure 8. TRAF2 deletion causes constitutive activation of non-canonical NF-κB 1066 
transcription factor. (A) Tnf-/-Traf2+/- and Tnf-/-Traf2-/- keratinocytes were treated with or 1067 
without TNF (100ng/ml) for the indicated times. The lysates were analysed as in Figure 1. 1068 
Asterisks indicate non-specific bands. (B) The viability of keratinocytes of the indicated 1069 
genotype was measured at indicated time points using an MTS assay. Viability following TNF 1070 
treatment (100ng/ml) on day 4 was used as a control. Data are represented as mean ± SEM, n=4 1071 
biological repeats. (C) Tnf-/-Traf2+/- and Tnf-/-Traf2-/- keratinocytes were treated with IL-17 1072 
(100ng/ml) for the indicated times and lysates analysed as previously. (D) Viability of 1073 
keratinocytes of indicated genotype ± IL-17 (100ng/ml) was measured at indicated time points 1074 
using MTS assay. Data are represented as mean ± SEM, n≥3 biological repeats. (E) Heat map 1075 
depicting a selection from qPCR analysis of more than 600 inflammatory genes from Tnf-/-1076 
Traf2+/- and Tnf-/-Traf2-/- keratinocytes (3 mice for each genotype). Log expression values have 1077 
been standardized to have mean 0 and standard deviation 1 for each row. Genes were ranked 1078 
based on the fold change expression. Gens above the dashed line were highly elevated in Tnf-/-1079 
Traf2-/- keratinocytes. Asterisks indicate significant changes with P values < 0.05. 1080 
 1081 
Figure 9. NIK mutation (aly) does not rescue the inflammation in Traf2EKO mice. (A) 1082 
Representative images and skin sections of mice with indicated genotypes. Scale bars = 100μm. 1083 
(B) Kaplan-Meier graph indicating the time that the mice with the skin lesions, needed to be 1084 
sacrificed according to animal ethics regulations. 1085 
 1086 
 1087 
Figure 10. Depletion of both Tnf and Nfkb2 rescues the skin inflammation caused by loss of 1088 
TRAF2 in keratinocytes. Depletion of both Tnf and Nfkb2 rescues skin inflammation 1089 
caused by TRAF2 deletion in keratinocytes. (A, B and C) Representative images and skin 1090 
sections of indicated mice stained with haematoxylin/eosin (H&E), immuno-stained for indicated 1091 
epidermal differentiation markers (in red) and nuclei (Hoechst; in blue) and immuno-1092 
histochemistry for pan leukocyte marker (CD45), cleaved caspase-3 (CC3) and toluidine blue 1093 
(TB). Scale bars = 100 μm. (D) Kaplan-Meier graph depicting survival of indicated mouse 1094 
strains. 1095 
 1096 
Figure 11. Proposed mechanisms by which loss of TRAF2 in keratinocytes causes a 1097 
psoriasis-like skin inflammation. (A) In normal wild type skin TNF signalling might be 1098 
activated by local penetration of bacteria into the epidermis. This will induce TNF presumably 1099 
by keratinocytes themselves or Langerhans cells and promotes canonical NF-κB signalling, 1100 
inflammatory cytokine production and expression of prosurvival genes. If this response nullifies 1101 
the threat, TNF signalling is turned off and homeostasis of the skin is maintained. (B) In the 1102 
absence of TRAF2 in keratinocytes, however TNF production can induce apoptotic cell death. 1103 
This cell death, possibly because of the release of DAMPs, recruits neutrophils and other 1104 
inflammatory cells to the skin and causes epidermal hyperplasia. At the same time, loss of 1105 
TRAF2 causes constitutive non-canonical NF-κB activation in the keratinocytes which increases 1106 
the production and release of inflammatory cytokines including TNF. Thus TRAF2 knock-out 1107 
keratinocytes do not need to be stimulated by bacteria to produce TNF and TNF induced death 1108 
sets up a potentially vicious cycle of inflammation (C) Concomitant deletion of Tnf in mice with 1109 
Traf2  deficient keratinocytes breaks this vicious cycle and prevents apoptosis of keratinocytes 1110 
and early onset of the psoriasis-like phenotype. (D) In the absence of TNF Traf2 deficient 1111 
keratinocytes still produce inflammatory cytokines via the non-canonical NF-κB pathway that 1112 
ultimately generate the same psoriasis-like phenotype in mice but with slower onset. These 1113 
cytokines recruit inflammatory immune cells to the skin including neutrophils and IFNγ+ T cells. 1114 
Source data files 1115 
Figure 8- source data 1. Complete zoom-able heat map of qPCR array. Heat map depicting a 1116 
selection from qPCR analysis of more than 600 inflammatory genes from Tnf-/-Traf2+/- and Tnf-/-1117 
Traf2-/- keratinocytes (3 mice for each genotype). Log expression values have been standardized 1118 
to have mean 0 and standard deviation 1 for each row. Genes were ranked based on the fold 1119 
change expression. 1120 
Figure 8- source data 2. Spreadsheet of result from qPCR array. 1121 











